The Role of GER in Exercise Triggered Asthma
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00204672|
Recruitment Status : Completed
First Posted : September 20, 2005
Last Update Posted : September 20, 2005
Gastroesophageal reflux is a major contributor to exercise-triggered asthma.
Two groups of patients will be studied: those with asthma who have difficulty with exertion, those without asthma who experience difficulty with exertion. Both groups will experience gastroesophageal reflux (GER) twice of less per week. Patients will complete a treadmill exam to determine their VO2 max. They will then undergo pH monitoring while exercising for 30 minutes at 65-70% of their VO2 max. Subjects will be given placebo or acid suppression pill for 12 weeks. At the end of 12 weeks, the subjects will repeat the exercise (30 minutes) and 24-hour pH study.
|Condition or disease||Intervention/treatment||Phase|
|Asthma||Drug: Achipex||Phase 2 Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||36 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||The Role of GER in Exercise Triggered Asthma|
|Study Start Date :||October 2000|
|Study Completion Date :||September 2005|
- To determine whether patients with exercise-triggered asthma experience GER during exercise.
- To determine whether the exercise-induced GER within the subjects relates temporally to their exertional asthma.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00204672
|United States, Utah|
|University of Utah|
|Salt Lake City, Utah, United States, 84132|
|Principal Investigator:||Kathryn A Peterson, M.D.||University of Utah|